Publizoom

Award notice Supplies

Suministro de tenecteplasa 10.000 unidades (50 mg) polvo y disolvente para solución inyectable y de idarucizumab 2,5 g/50 ml solución inyectable y para perfusión 2 viales de 50 ml, ambos de distribucion exclusiva por el laboratorio boehringer ingelheim, con destino al servicio de farmacia del summa 112 de madrid

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
SERVICIO DE URGENCIAS MÉDICAS DE MADRID - SUMMA 112
MADRID
Place of performance
MADRID
Estimated value
€285,256 excl. VAT
Amount awarded
€148,333 excl. VAT
Planned end of contract
31 August 2027
likely re-tender around March 2027
Bids received
1
Procedure
Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication
3 September 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

SUMINISTRO DE TENECTEPLASA 10.000 UNIDADES (50 MG) POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y DE IDARUCIZUMAB 2,5 G/50 ML SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN 2 VIALES DE 50 ML, AMBOS DE DISTRIBUCION EXCLUSIVA POR EL LABORATORIO BOEHRINGER INGELHEIM, CON DESTINO AL SERVICIO DE FARMACIA DEL SUMMA 112 DE MADRID

Awarded to

2 lots

  • PNSP/SU/01/26 LOTE 1
  • PNSP/SU/01/26 LOTE 2

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€350,000
Median
€846,164
A quarter above
€2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Suministro de medicamentos exclusivos del laboratorio VIIV HEALTHCARE S.L. para la Gerencia de Atención Sanitaria de Melilla
Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria · 23 October 2026
LABORATORIOS VIIV HEALTHCARE S.L. €126,595
Suministro de IODIXANOL (VISIPAQUE) E IOHEXOL (OMNIPAQUE) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos
HOSPITAL CLINICO SAN CARLOS · 23 October 2026
GE HEALTHCARE BIO-SCIENCES, SAU €505,350
Suministro de Tafasitamab (DOE)
OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026
INCYTE BIOSCIENCES IBERIA, S.L. €2,170,000
Cbam 494/2025 janssen cilag/28
Servicio Andaluz de Salud · 23 October 2026
JANSSEN-CILAG, S.A. €353,000
Adjudicación del Contrato Específico del Medicamento FUMARATO DE DIROXIMEL, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral
Consorci Sanitari Integral · 23 October 2026
BIOGEN SPAIN S.L. €277,262

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 608813-2026.